世界の成長ホルモン分泌促進物質受容体タイプ1市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV07000)
◆英語タイトル:Global Growth Hormone Secretagogue Receptor Type 1 Market Insights and Forecast to 2026
◆商品コード:QYR20NV07000
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは成長ホルモン分泌促進物質受容体タイプ1の世界市場について調査・分析した資料です。種類別(AZP-531、EXT-400、HM-01、OXE-103、その他)の市場規模、用途別(放射線毒性、化学療法効果、アルコール依存症、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別成長ホルモン分泌促進物質受容体タイプ1の競争状況、市場シェア
・世界の成長ホルモン分泌促進物質受容体タイプ1市場:種類別市場規模 2015年-2020年(AZP-531、EXT-400、HM-01、OXE-103、その他)
・世界の成長ホルモン分泌促進物質受容体タイプ1市場:種類別市場規模予測 2021年-2026年(AZP-531、EXT-400、HM-01、OXE-103、その他)
・世界の成長ホルモン分泌促進物質受容体タイプ1市場:用途別市場規模 2015年-2020年(放射線毒性、化学療法効果、アルコール依存症、その他)
・世界の成長ホルモン分泌促進物質受容体タイプ1市場:用途別市場規模予測 2021年-2026年(放射線毒性、化学療法効果、アルコール依存症、その他)
・北米の成長ホルモン分泌促進物質受容体タイプ1市場分析:米国、カナダ
・ヨーロッパの成長ホルモン分泌促進物質受容体タイプ1市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの成長ホルモン分泌促進物質受容体タイプ1市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の成長ホルモン分泌促進物質受容体タイプ1市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの成長ホルモン分泌促進物質受容体タイプ1市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Aeterna Zentaris Inc、Alize Pharma SAS、Allergan Plc、AstraZeneca Plc、Daiichi Sankyo Co Ltd、Oxeia Biopharmaceuticals Inc、Pfizer Inc、RaQualia Pharma Inc、Zeria Pharmaceutical Co Ltd
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Growth Hormone Secretagogue Receptor Type 1 Market
The global Growth Hormone Secretagogue Receptor Type 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Growth Hormone Secretagogue Receptor Type 1 Scope and Market Size
Growth Hormone Secretagogue Receptor Type 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Growth Hormone Secretagogue Receptor Type 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Growth Hormone Secretagogue Receptor Type 1 market is segmented into
AZP-531
EXT-400
HM-01
OXE-103
Others

Segment by Application, the Growth Hormone Secretagogue Receptor Type 1 market is segmented into
Radiation Toxicity
Chemotherapy Effects
Alconol Addiction
Others

Regional and Country-level Analysis
The Growth Hormone Secretagogue Receptor Type 1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Growth Hormone Secretagogue Receptor Type 1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Growth Hormone Secretagogue Receptor Type 1 Market Share Analysis
Growth Hormone Secretagogue Receptor Type 1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Growth Hormone Secretagogue Receptor Type 1 business, the date to enter into the Growth Hormone Secretagogue Receptor Type 1 market, Growth Hormone Secretagogue Receptor Type 1 product introduction, recent developments, etc.

The major vendors covered:
Aeterna Zentaris Inc
Alize Pharma SAS
Allergan Plc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Oxeia Biopharmaceuticals Inc
Pfizer Inc
RaQualia Pharma Inc
Zeria Pharmaceutical Co Ltd

【レポートの目次】

1 Study Coverage
1.1 Growth Hormone Secretagogue Receptor Type 1 Product Introduction
1.2 Market Segments
1.3 Key Growth Hormone Secretagogue Receptor Type 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Growth Hormone Secretagogue Receptor Type 1 Market Size Growth Rate by Type
1.4.2 AZP-531
1.4.3 EXT-400
1.4.4 HM-01
1.4.5 OXE-103
1.4.6 Others
1.5 Market by Application
1.5.1 Global Growth Hormone Secretagogue Receptor Type 1 Market Size Growth Rate by Application
1.5.2 Radiation Toxicity
1.5.3 Chemotherapy Effects
1.5.4 Alconol Addiction
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Growth Hormone Secretagogue Receptor Type 1 Market Size, Estimates and Forecasts
2.1.1 Global Growth Hormone Secretagogue Receptor Type 1 Revenue 2015-2026
2.1.2 Global Growth Hormone Secretagogue Receptor Type 1 Sales 2015-2026
2.2 Global Growth Hormone Secretagogue Receptor Type 1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Growth Hormone Secretagogue Receptor Type 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Growth Hormone Secretagogue Receptor Type 1 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Growth Hormone Secretagogue Receptor Type 1 Competitor Landscape by Players
3.1 Growth Hormone Secretagogue Receptor Type 1 Sales by Manufacturers
3.1.1 Growth Hormone Secretagogue Receptor Type 1 Sales by Manufacturers (2015-2020)
3.1.2 Growth Hormone Secretagogue Receptor Type 1 Sales Market Share by Manufacturers (2015-2020)
3.2 Growth Hormone Secretagogue Receptor Type 1 Revenue by Manufacturers
3.2.1 Growth Hormone Secretagogue Receptor Type 1 Revenue by Manufacturers (2015-2020)
3.2.2 Growth Hormone Secretagogue Receptor Type 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Growth Hormone Secretagogue Receptor Type 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Growth Hormone Secretagogue Receptor Type 1 Revenue in 2019
3.2.5 Global Growth Hormone Secretagogue Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Growth Hormone Secretagogue Receptor Type 1 Price by Manufacturers
3.4 Growth Hormone Secretagogue Receptor Type 1 Manufacturing Base Distribution, Product Types
3.4.1 Growth Hormone Secretagogue Receptor Type 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Growth Hormone Secretagogue Receptor Type 1 Product Type
3.4.3 Date of International Manufacturers Enter into Growth Hormone Secretagogue Receptor Type 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Growth Hormone Secretagogue Receptor Type 1 Market Size by Type (2015-2020)
4.1.1 Global Growth Hormone Secretagogue Receptor Type 1 Sales by Type (2015-2020)
4.1.2 Global Growth Hormone Secretagogue Receptor Type 1 Revenue by Type (2015-2020)
4.1.3 Growth Hormone Secretagogue Receptor Type 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global Growth Hormone Secretagogue Receptor Type 1 Sales Forecast by Type (2021-2026)
4.2.2 Global Growth Hormone Secretagogue Receptor Type 1 Revenue Forecast by Type (2021-2026)
4.2.3 Growth Hormone Secretagogue Receptor Type 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Growth Hormone Secretagogue Receptor Type 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Growth Hormone Secretagogue Receptor Type 1 Market Size by Application (2015-2020)
5.1.1 Global Growth Hormone Secretagogue Receptor Type 1 Sales by Application (2015-2020)
5.1.2 Global Growth Hormone Secretagogue Receptor Type 1 Revenue by Application (2015-2020)
5.1.3 Growth Hormone Secretagogue Receptor Type 1 Price by Application (2015-2020)
5.2 Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global Growth Hormone Secretagogue Receptor Type 1 Sales Forecast by Application (2021-2026)
5.2.2 Global Growth Hormone Secretagogue Receptor Type 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global Growth Hormone Secretagogue Receptor Type 1 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Growth Hormone Secretagogue Receptor Type 1 by Country
6.1.1 North America Growth Hormone Secretagogue Receptor Type 1 Sales by Country
6.1.2 North America Growth Hormone Secretagogue Receptor Type 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Type
6.3 North America Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Application

7 Europe
7.1 Europe Growth Hormone Secretagogue Receptor Type 1 by Country
7.1.1 Europe Growth Hormone Secretagogue Receptor Type 1 Sales by Country
7.1.2 Europe Growth Hormone Secretagogue Receptor Type 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Type
7.3 Europe Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Growth Hormone Secretagogue Receptor Type 1 by Region
8.1.1 Asia Pacific Growth Hormone Secretagogue Receptor Type 1 Sales by Region
8.1.2 Asia Pacific Growth Hormone Secretagogue Receptor Type 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Type
8.3 Asia Pacific Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Growth Hormone Secretagogue Receptor Type 1 by Country
9.1.1 Latin America Growth Hormone Secretagogue Receptor Type 1 Sales by Country
9.1.2 Latin America Growth Hormone Secretagogue Receptor Type 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Type
9.3 Central & South America Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Growth Hormone Secretagogue Receptor Type 1 by Country
10.1.1 Middle East and Africa Growth Hormone Secretagogue Receptor Type 1 Sales by Country
10.1.2 Middle East and Africa Growth Hormone Secretagogue Receptor Type 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Type
10.3 Middle East and Africa Growth Hormone Secretagogue Receptor Type 1 Market Facts & Figures by Application

11 Company Profiles
11.1 Aeterna Zentaris Inc
11.1.1 Aeterna Zentaris Inc Corporation Information
11.1.2 Aeterna Zentaris Inc Description and Business Overview
11.1.3 Aeterna Zentaris Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aeterna Zentaris Inc Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.1.5 Aeterna Zentaris Inc Related Developments
11.2 Alize Pharma SAS
11.2.1 Alize Pharma SAS Corporation Information
11.2.2 Alize Pharma SAS Description and Business Overview
11.2.3 Alize Pharma SAS Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alize Pharma SAS Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.2.5 Alize Pharma SAS Related Developments
11.3 Allergan Plc
11.3.1 Allergan Plc Corporation Information
11.3.2 Allergan Plc Description and Business Overview
11.3.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Allergan Plc Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.3.5 Allergan Plc Related Developments
11.4 AstraZeneca Plc
11.4.1 AstraZeneca Plc Corporation Information
11.4.2 AstraZeneca Plc Description and Business Overview
11.4.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AstraZeneca Plc Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.4.5 AstraZeneca Plc Related Developments
11.5 Daiichi Sankyo Co Ltd
11.5.1 Daiichi Sankyo Co Ltd Corporation Information
11.5.2 Daiichi Sankyo Co Ltd Description and Business Overview
11.5.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Daiichi Sankyo Co Ltd Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.5.5 Daiichi Sankyo Co Ltd Related Developments
11.6 Oxeia Biopharmaceuticals Inc
11.6.1 Oxeia Biopharmaceuticals Inc Corporation Information
11.6.2 Oxeia Biopharmaceuticals Inc Description and Business Overview
11.6.3 Oxeia Biopharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Oxeia Biopharmaceuticals Inc Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.6.5 Oxeia Biopharmaceuticals Inc Related Developments
11.7 Pfizer Inc
11.7.1 Pfizer Inc Corporation Information
11.7.2 Pfizer Inc Description and Business Overview
11.7.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Inc Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.7.5 Pfizer Inc Related Developments
11.8 RaQualia Pharma Inc
11.8.1 RaQualia Pharma Inc Corporation Information
11.8.2 RaQualia Pharma Inc Description and Business Overview
11.8.3 RaQualia Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 RaQualia Pharma Inc Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.8.5 RaQualia Pharma Inc Related Developments
11.9 Zeria Pharmaceutical Co Ltd
11.9.1 Zeria Pharmaceutical Co Ltd Corporation Information
11.9.2 Zeria Pharmaceutical Co Ltd Description and Business Overview
11.9.3 Zeria Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Zeria Pharmaceutical Co Ltd Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.9.5 Zeria Pharmaceutical Co Ltd Related Developments
11.1 Aeterna Zentaris Inc
11.1.1 Aeterna Zentaris Inc Corporation Information
11.1.2 Aeterna Zentaris Inc Description and Business Overview
11.1.3 Aeterna Zentaris Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aeterna Zentaris Inc Growth Hormone Secretagogue Receptor Type 1 Products Offered
11.1.5 Aeterna Zentaris Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Growth Hormone Secretagogue Receptor Type 1 Market Estimates and Projections by Region
12.1.1 Global Growth Hormone Secretagogue Receptor Type 1 Sales Forecast by Regions 2021-2026
12.1.2 Global Growth Hormone Secretagogue Receptor Type 1 Revenue Forecast by Regions 2021-2026
12.2 North America Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast (2021-2026)
12.2.1 North America: Growth Hormone Secretagogue Receptor Type 1 Sales Forecast (2021-2026)
12.2.2 North America: Growth Hormone Secretagogue Receptor Type 1 Revenue Forecast (2021-2026)
12.2.3 North America: Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.3 Europe Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast (2021-2026)
12.3.1 Europe: Growth Hormone Secretagogue Receptor Type 1 Sales Forecast (2021-2026)
12.3.2 Europe: Growth Hormone Secretagogue Receptor Type 1 Revenue Forecast (2021-2026)
12.3.3 Europe: Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Growth Hormone Secretagogue Receptor Type 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Growth Hormone Secretagogue Receptor Type 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: Growth Hormone Secretagogue Receptor Type 1 Sales Forecast (2021-2026)
12.5.2 Latin America: Growth Hormone Secretagogue Receptor Type 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Growth Hormone Secretagogue Receptor Type 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Growth Hormone Secretagogue Receptor Type 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Growth Hormone Secretagogue Receptor Type 1 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Growth Hormone Secretagogue Receptor Type 1 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Growth Hormone Secretagogue Receptor Type 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Aeterna Zentaris Inc、Alize Pharma SAS、Allergan Plc、AstraZeneca Plc、Daiichi Sankyo Co Ltd、Oxeia Biopharmaceuticals Inc、Pfizer Inc、RaQualia Pharma Inc、Zeria Pharmaceutical Co Ltd

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の成長ホルモン分泌促進物質受容体タイプ1市場2026:インサイト・予測(Global Growth Hormone Secretagogue Receptor Type 1 Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。